CytoMed Therapeutics Limited (GDTC) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.90
-8.16%
Mkt Cap $12.44M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q3 2025 Sep 30, 2025 | — | $105.70K | — | — | -$0.07 | — | — | — |
| Q1 2025 Mar 31, 2025 | — | $74.29K | — | — | -$0.05 | — | — | — |
| Q3 2024 Sep 30, 2024 | — | $83.26K | — | — | -$0.04 | — | — | — |
| Q2 2024 Jun 30, 2024 | — | $61.01K | — | — | -$0.05 | — | — | — |
| Q2 2024 May 6, 2024 | — | $63.95K | — | — | -$0.05 | — | — | — |
| Q1 2024 Mar 31, 2024 | — | $61.42K | — | — | -$0.03 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | $59.70K | — | — | -$0.05 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $77.64K | — | — | -$0.10 | — | — | — |
| Q2 2023 May 1, 2023 | — | $80.24K | — | — | -$0.10 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | $80.34K | — | — | -$0.06 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | $70.22K | — | — | -$0.06 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.07 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | $20.28K | — | — | -$0.04 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.08 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $23.09K | — | — | -$0.04 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.08 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $7.91K | — | — | -$0.04 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | $17.01K | — | — | -$0.07 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | $15.96K | — | — | -$0.06 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$0.02 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.02 | — | — | — |